CHMP recommends granting marketing authorization to Nycomed's Pantozol Control Feb. 20, 2009 No Comments
CHMP recommends marketing authorization for Pfizer's Fablyn in osteoporosis Dec. 29, 2008 No Comments
Oncoscience withdraws Theraloc (nimotuzumab) marketing authorization application Dec. 5, 2008 No Comments
Further explanation of CHMP's negative opinion for Santhera's Sovrima for Friedreich's ataxia Nov. 25, 2008 No Comments
EMEA recommends temporary suspension of Acomplia marketing authorization in obese patients Oct. 24, 2008 No Comments